glp 1 greens Natalie GLP-1 Gut Health Daily Green

This weeks Dear Laura is about GLP-1s, shame, and the fear of being judged for choosing help.

Insurance coverage for GLP-1 weight loss drugs remains limited and unpredictable

2 Key Trends: The Next Generation Will Compete on Convenience and Potency Formulation Innovation Oral GLP-1 products are emerging as a major frontier, with over 10 oral candidates in development

Food and Drug Administration has not

Collaborations and partnerships reflecting agility and specialization will become the new currencies of market advantage.

Time-to-onset analysis revealed a median latency of 32 days (IQR 7122) for GLP-1 RA-related NAEs, with 45.28% occurring within 30 days of treatment initiation